Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Polycystic Kidney, Autosomal Dominant

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Polycystic Kidney, Autosomal Dominant in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Polycystic Kidney, Autosomal Dominant: Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.

Research Excerpts

ExcerptRelevanceReference
"There are many parallels between ADPKD and clear-cell renal cell carcinoma (ccRCC); however, few studies have addressed the mechanisms linking them."1.62NS398 as a potential drug for autosomal-dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models. ( Chen, S; Fu, L; Huang, L; Mao, Z; Mei, C; Ruan, M; Xu, D; Yang, B; Zhang, Q; Zhou, S, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, S1
Huang, L1
Zhou, S1
Zhang, Q1
Ruan, M1
Fu, L1
Yang, B1
Xu, D1
Mei, C1
Mao, Z1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Polycystic Kidney, Autosomal Dominant

ArticleYear
NS398 as a potential drug for autosomal-dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models.
    Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:20

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Computational Biology; Cyclooxygenase Inhi

2021